Cystinuria in children:: Distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes

被引:45
|
作者
Botzenhart, E
Vester, U
Schmidt, C
Hesse, A
Halber, M
Wagner, C
Lang, F
Hoyer, P
Zerres, K
Eggermann, T
机构
[1] Rhein Westfal TH Aachen, Inst Human Genet, D-52074 Aachen, Germany
[2] Univ Essen Gesamthsch, Childrens Hosp, Essen, Germany
[3] Dept Urol, Div Expt Urol, Bonn, Germany
[4] Univ Zurich, Inst Physiol, Zurich, Switzerland
[5] Univ Tubingen, Inst Physiol, Tubingen, Germany
关键词
nephrolithiasis; pediatric cystinuria; defective renal reabsorption; heredity; amino acid transport; hyperexcretion of cystine; renal stone formation;
D O I
10.1046/j.1523-1755.2002.00552.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Cystinuria is a common inherited disorder of defective renal reabsorption of cystine, ornithine, lysine and arginine leading to nephrolithiasis. Two responsible genes have been identified so far: Mutations in the SLC3A1 gene encoding the heavy chain rbAT of the renal cystine transport system rbAT/b(0,+) AT cause cystinuria type I, while variants in SLC7A9 , the gene of its light chain b(0,+) AT, have been demonstrated in non-type I cystinuria. In this study, we searched for mutations in both genes in a cohort of children with cystinuria. Methods. Twenty-one cystinuric children from 16 families were analyzed by mutational analysis of the genes SLC3A1 and the SLC7A9 . The patients were classified by the urinary amino acid excretion profile of their parents. Additionally, 10 unclassified patients were screened for genomic variants. The screening techniques included single strand conformation polymorphism analysis, restriction assays and direct sequencing. Results. Two novel mutations were identified in SLC3A1 and three in SLC7A9 ; three were missense mutations and two frameshift mutations. In the pediatric patients, mutations were found in 54% of type I (SLC3A1 ) and in 25% of non-type I (SLC7A9 ) chromosomes. For this group of patients a total detection rate of 46.6% for mutations in both genes was delineated. In the cohort of unclassified 10 patients, 70% of mutations were determined. M467T and G105R were the preponderant mutations in SLC3A1 and SLC7A9 , respectively; T216M was the major mutation in Turkey and Greece. Conclusions. The detection rate for mutations in SLC3A1 and SLC7A9 in children was 54% in the SLC3A1 gene for type I chromosomes and 25% in the SLC7A9 gene for non-type I chromosomes. It was lower than that in 10 further patients with an unclassified cystinuria, although the clinical characterization in the first group was more stringent; additionally, different spectrums of mutations were observed. The lack of detectable mutations in many patients indicates the possibility of other yet unidentified genes involved in cystinuria. We could not correlate the severity of the disease to the type of cystinuria in the pediatric patients.
引用
收藏
页码:1136 / 1142
页数:7
相关论文
共 50 条
  • [21] Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes
    Di Perna, Michele
    Louizou, Eirini
    Fischetti, Lucia
    Dedoussis, George V. Z.
    Stanziale, Pietro
    Michelakakis, Helen
    Zelante, Leopoldo
    Pras, Elon
    Bisceglia, Luigi
    GENETIC TESTING, 2008, 12 (03): : 351 - 355
  • [22] Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers:: A need for a new classification
    Dello Strologo, L
    Pras, E
    Pontesilli, C
    Beccia, E
    Ricci-Barbini, V
    De Sanctis, L
    Ponzone, A
    Gallucci, M
    Bisceglia, L
    Zelante, L
    Jimenez-Vidal, M
    Font, M
    Zorzano, A
    Rousaud, F
    Nunes, V
    Gasparini, P
    Palacín, M
    Rizzoni, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10): : 2547 - 2553
  • [23] Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: A need for a new classification.
    Dello Strologo, L
    Pras, E
    Pontesilli, C
    Beccia, E
    Ricci-Barbini, V
    de Sanctis, L
    Ponzone, A
    Gallucci, M
    Bisceglia, L
    Zelante, L
    Jimenez-Vidal, M
    Font, M
    Zorzano, A
    Rosaud, F
    Nunes, V
    Gasparini, P
    Palacin, M
    Rizzoni, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 131A - 132A
  • [24] Analysis of the genes SLC7A9 and SLC3A1 in unclassified cystinurics: mutation detection rates and association between variants in SLC7A9 and the disease
    Schmidt, C
    Albers, A
    Tomiuk, J
    Eggermann, K
    Wagner, C
    Capasso, G
    Lahme, S
    Hesse, A
    Lang, F
    Zerres, K
    Eggermann, T
    CLINICAL NEPHROLOGY, 2002, 57 (05) : 342 - 348
  • [25] Interpretation of SLC3A1 and SLC7A9 variants in cystinuria patients: The significance of the PM3 criterion and protein stability
    Beomki Lee
    Soo-Youn Lee
    Deok Hyun Han
    Hyung-Doo Park
    Urolithiasis, 51
  • [26] Interpretation of SLC3A1 and SLC7A9 variants in cystinuria patients: The significance of the PM3 criterion and protein stability
    Lee, Beomki
    Lee, Soo-Youn
    Han, Deok Hyun
    Park, Hyung-Doo
    UROLITHIASIS, 2023, 51 (01)
  • [27] SLC7A9 mutations in all three cystinuria subtypes
    Leclerc, D
    Boutros, M
    Suh, D
    Wu, Q
    Palacin, M
    Ellis, JR
    Goodyer, P
    Rozen, R
    KIDNEY INTERNATIONAL, 2002, 62 (05) : 1550 - 1559
  • [28] Molecular genetic analysis of SLC3A1 and SLC7A9 genes in Czech and Slovak cystinuric patients
    Skopková, Z
    Hrabincová, E
    Stástná, S
    Kozák, L
    Adam, T
    ANNALS OF HUMAN GENETICS, 2005, 69 : 501 - 507
  • [29] Molecular diagnostic tests identifying carriers of SLC3A1 and SLC7A9 gene mutations in domestic cats
    Kaluska, J.
    Gruszczynska, J.
    Grzegrzolka, B.
    REPRODUCTION IN DOMESTIC ANIMALS, 2022, 57 : 100 - 100
  • [30] The role of double heterozygotes of SLC3A1 and SLC7A9 in the prevalence of cystine stones
    Wu, Chen-Han Wilfred
    Patel, Ishita
    Lovrenert, Katreya
    Eisner, Brian
    Meeks, Naomi
    Tsai, Anne Chun-Hui
    Baum, Michelle
    Berry, Gerard
    Schumacher, Fredrick R.
    GENETICS IN MEDICINE, 2025, 27 (01)